Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Solid Tumor × Celecoxib × Clear all

Sponsor

Conditions

Colorectal Neoplasms 9 Breast Neoplasms 9 Colonic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Rectal Neoplasms 4 Lung Neoplasms 4 Head and Neck Neoplasms 4 Adenomatous Polyposis Coli 4 Sarcoma 3 Glioblastoma 3 Central Nervous System Neoplasms 3 Paranasal Sinus Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Laryngeal Neoplasms 2 Gliosarcoma 2 Breast Carcinoma In Situ 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Tobacco Use Disorder 1 Stomatitis 1 Smoldering Multiple Myeloma 1 Smoking 1 Recurrence 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1 Precancerous Conditions 1

Interventions

Nivolumab 4 pertuzumab 2 pembrolizumab 2 durvalumab 2 Paclitaxel 2 Docetaxel 2 Capecitabine 2 ulocuplumab 1 tremelimumab 1 tazarotene 1 talazoparib 1 romiplostim 1 pexidartinib 1 pamiparib 1 onartuzumab 1 magrolimab 1 entrectinib 1 cobimetinib 1 atezolizumab 1 Sunitinib 1 Rifampin 1 Ramucirumab 1 Radiosurgery 1 N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 1 Midazolam 1 MK-4166 1 LY3022855 1 LY2510924 1 LY-2157299 1 Itraconazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡